MiNK Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
MiNK Therapeutics Current Ratio Growth & History (INKT)
MiNK Therapeutics's current ratio was 1.06 for fiscal 2025.
View full MiNK Therapeutics company overviewMiNK Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.06 | 0.35 | +48.27% |
| 2024 | 2024-12-31 | 0.72 | 0.40 | +127.11% |
| 2023 | 2023-12-31 | 0.32 | −1.29 | −80.38% |
| 2022 | 2022-12-31 | 1.61 | −0.80 | −33.17% |
| 2021 | 2021-12-31 | 2.41 | 2.12 | +735.68% |
| 2020 | 2020-12-31 | 0.29 | — | — |
MiNK Therapeutics quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.23 | 1.08 | +703.94% |
| Q1 2026 | 2026-03-31 | 1.38 | 1.08 | +365.63% |
| Q4 2025 | 2025-12-31 | 1.06 | 0.35 | +48.27% |
| Q3 2025 | 2025-09-30 | 1.08 | 0.19 | +21.75% |
| Q2 2025 | 2025-06-30 | 0.15 | −0.78 | −83.63% |
| Q1 2025 | 2025-03-31 | 0.30 | −0.24 | −45.31% |
| Q4 2024 | 2024-12-31 | 0.72 | 0.40 | +127.11% |
| Q3 2024 | 2024-09-30 | 0.89 | 0.27 | +42.76% |
| Q2 2024 | 2024-06-30 | 0.93 | −0.03 | −3.17% |
| Q1 2024 | 2024-03-31 | 0.54 | −0.84 | −60.86% |
| Q4 2023 | 2023-12-31 | 0.32 | −1.29 | −80.38% |
| Q3 2023 | 2023-09-30 | 0.62 | −0.70 | −53.05% |
| Q2 2023 | 2023-06-30 | 0.96 | −0.78 | −44.60% |
| Q1 2023 | 2023-03-31 | 1.38 | −0.50 | −26.75% |
| Q4 2022 | 2022-12-31 | 1.61 | −0.80 | −33.17% |
| Q3 2022 | 2022-09-30 | 1.33 | 1.28 | +3003.61% |
| Q2 2022 | 2022-06-30 | 1.74 | — | — |
| Q1 2022 | 2022-03-31 | 1.88 | — | — |
| Q4 2021 | 2021-12-31 | 2.41 | 2.12 | +735.68% |
| Q3 2021 | 2021-09-30 | 0.04 | — | — |
| Q4 2020 | 2020-12-31 | 0.29 | — | — |
MiNK Therapeutics current ratio trends
Over the last five fiscal years, MiNK Therapeutics's current ratio increased from 0.29 to 1.06, a change of 0.77. The latest reported quarter, Q2 2026, shows 1.23.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MiNK Therapeutics source filings ↗